Charles River Laboratories (CRL)
Net profit margin
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | 22,203 | 474,624 | 486,226 | 390,982 | 364,304 |
Revenue | US$ in thousands | 4,120,490 | 4,082,940 | 4,098,090 | 3,457,220 | 2,939,570 |
Net profit margin | 0.54% | 11.62% | 11.86% | 11.31% | 12.39% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $22,203K ÷ $4,120,490K
= 0.54%
The net profit margin of Charles River Laboratories has shown a gradual decline from 12.39% as of December 31, 2020, to 11.31% as of December 31, 2021, indicating a slight decrease in the company's ability to convert revenue into profits in that period. However, there was a modest improvement in the net profit margin to 11.86% as of December 31, 2022, before declining again to 11.62% as of December 31, 2023. The most significant drop occurred in the latest year, with the net profit margin plummeting to 0.54% as of December 31, 2024, suggesting a substantial decrease in profitability and efficiency in converting sales into net income. It is essential for the company to closely monitor and address this sharp decline to sustain its financial performance and ensure long-term profitability.
Peer comparison
Dec 31, 2024